Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA

BACKGROUND: Array-CGH represents a comprehensive tool to discover genomic disease alterations that could potentially be applied to body fluids. In this report, we aimed at applying array-CGH to urinary samples to characterize bladder cancer. METHODS: Urinary DNA from bladder cancer patients and cont...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: López, Virginia, González-Peramato, Pilar, Suela, Javier, Serrano, Alvaro, Algaba, Ferrán, Cigudosa, Juan C, Vidal, August, Bellmunt, Joaquim, Heredero, Oscar, Sánchez-Carbayo, Marta
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2013
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3750577/
https://ncbi.nlm.nih.gov/pubmed/23914742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-11-182
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares